CBT
Get informed when a big investor buys or sells
+ FollowUndervalued by 198.6% based on the discounted cash flow analysis.
| Market cap | $4.54 Billion |
|---|---|
| Enterprise Value | $5.58 Billion |
| Dividend Yield | $1.82 (2.07%) |
| Earnings per Share | $6.07 |
| Beta | 0.83 |
| Outstanding Shares | 51,600,000 |
| P/E Ratio | 24.34 |
|---|---|
| PEG | -25.88 |
| Price to Sales | 1.23 |
| Price to Book Ratio | 2.61 |
| Enterprise Value to Revenue | 1.54 |
| Enterprise Value to EBIT | 11 |
| Enterprise Value to Net Income | 29 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.81 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 64.78% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 26.50%▼ 70.68% |
|---|---|
| Total Invested | $1.25B▼ 67.54% |
| Investors Holding | 183▼ 193.00% |
No data